Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

‘No good evidence’ for self-monitoring in non-insulin diabetes

Self-monitoring of blood glucose is of limited use in patients with type 2 diabetes who are not using insulin, finds a new analysis.

The Cochrane review looked at 12 randomised controlled trials including 3,259 patients with diabetes not using insulin who self-monitored their blood glucose.

They found only a small statistically significant decrease in HbA1c at six month follow-up - of 0.3% - compared to control groups of patients who did not monitor at all. By 12-months, there was no significant decrease (0.1%) and self-monitoring of blood glucose also showed no significant effects on measures of patient satisfaction, general well-being or health-related quality of life.

The authors concluded that while self-monitoring of blood glucose was effective for patients with type 1 diabetes, and those with type 2 diabetes who are using insulin, there was little to support wider use.

NICE guidelines currently recommend self-monitoring is offered only as an ‘integral part' of self management education.

Study lead Dr Uriëll Malanda, a GP researcher at the EMGO Institute for Health and Care Research, Amsterdam, Netherlands said: ‘More research is needed to explore the psychological impact of self monitoring blood glucose and its accompanying demands on diabetes specific quality of life and well-being.'


The Cochrane Collaboration 2012, CD005060

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say